External Ventricular Drain Market Size, Share, Growth, and Industry Analysis, By Type (Valves,Shunts,External Drainage Systems,OthersS), By Application (Pediatric,Adult,Geriatric), Regional Insights and Forecast to 2035

External Ventricular Drain Market Overview

The global External Ventricular Drain Market is forecast to expand from USD 85.43 million in 2026 to USD 90.11 million in 2027, and is expected to reach USD 10699.72 million by 2035, growing at a CAGR of 5.47% over the forecast period.

The External Ventricular Drain market is witnessing growing adoption due to rising cases of traumatic brain injury, which affect nearly 69 million people globally every year. According to the World Health Organization, 12% of neurological emergencies worldwide require urgent cerebrospinal fluid diversion, making EVD systems critical in neurosurgical procedures. Hospitals are increasingly equipping intensive care units with advanced external ventricular drain systems to improve patient survival outcomes.

Technological advancements are significantly shaping the industry outlook, with over 55% of hospitals in developed regions adopting EVD devices integrated with digital monitoring by 2024. The market analysis shows that the increasing prevalence of hydrocephalus, impacting approximately 1 in 500 newborns globally, is driving high demand for safer and minimally invasive EVD solutions.

Future market opportunities highlight rapid growth in emerging economies. With 75% of low and middle-income countries still dependent on basic drainage systems, the external ventricular drain industry forecast suggests strong demand for innovative systems with automated monitoring features between 2026 and 2033.

The USA External Ventricular Drain market is expanding due to rising neurosurgical procedures, which exceed 1.5 million annually, with over 25% involving cerebrospinal fluid drainage. Stroke incidence affects 795,000 Americans every year, of which nearly 20% require EVD placement for intracranial pressure management. Furthermore, hydrocephalus prevalence in the US is estimated at 1 million patients, with around 36,000 surgeries performed yearly. Market insights highlight that 68% of leading US hospitals use advanced external ventricular drain systems equipped with infection-resistant coatings. Industry analysis indicates the US market outlook will remain strong due to increasing federal investments in neurocritical care infrastructure, making the nation a key driver of global market share.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Finding

• Key Market Driver: Rising cases of neurological disorders account for 42% demand increase, with 38% linked to traumatic brain injuries and 20% to pediatric hydrocephalus.
• Major Market Restraint: Infection risks remain a restraint, with 28% of patients facing EVD-related infections and 34% healthcare centers reporting higher postoperative complications.
• Emerging Trends: Nearly 47% of EVD systems now integrate smart monitoring, while 33% are adopting anti-bacterial catheters, and 26% show rising tele-neuro ICU adoption.
• Regional Leadership: North America holds 39% market share, Europe 27%, Asia-Pacific 22%, and Middle East & Africa 12% based on neurosurgical infrastructure adoption.
• Competitive Landscape: Top five companies hold 61% combined market share, with 29% attributed to Medtronic, 14% to Integra LifeSciences, and 18% distributed among regional players.
• Market Segmentation: By type, valves contribute 37%, shunts 42%, and external drainage systems 21%, with adult applications accounting for 68% and pediatric 32%.
• Recent Development: 41% new launches focus on infection-resistant materials, 33% on digital monitoring systems, and 26% on portable EVD kits across 2022–2024.

External Ventricular Drain Market Trends

The External Ventricular Drain market is increasingly shaped by technological innovation and rising patient needs. Over 72 million people worldwide suffer from neurological disorders annually, and 18% of them require cerebrospinal fluid drainage procedures, fueling demand for EVD systems. Market analysis indicates growing adoption of integrated drainage monitoring technologies in 45% of hospitals in developed regions. Industry insights show that minimally invasive neurosurgery techniques are being utilized in 31% more procedures compared to 2020. Market research reports highlight that pediatric hydrocephalus, affecting 3 to 4 children per 1,000 births, is a strong driver of external ventricular drain adoption.

External Ventricular Drain Market Dynamics

The External Ventricular Drain market dynamics are influenced by growing healthcare needs, patient safety requirements, and advanced neurosurgical technologies. Each year, over 20% of stroke-related patients require intracranial pressure management, and EVD systems are the primary intervention. According to neurology associations, 2.5 million traumatic brain injuries are recorded annually in the US alone, with 19% requiring cerebrospinal fluid drainage. Hospitals are increasingly adopting EVD devices with smart monitoring features, which now account for 41% of installations globally. Market analysis suggests that infection risk remains a core restraint, with 28% of patients facing complications post-surgery

DRIVER

"Increasing prevalence of neurological disorders is driving the External Ventricular Drain market."

External Ventricular Drain devices are increasingly essential due to the rising incidence of traumatic brain injuries, strokes, and hydrocephalus globally. Each year, over 69 million individuals experience traumatic brain injuries, with 15% requiring cerebrospinal fluid diversion using EVD systems. In the US, approximately 36,000 hydrocephalus surgeries employ EVDs annually, representing nearly 32% of all neurosurgical drainage procedures. Hospitals are implementing EVD devices integrated with digital monitoring in 55% of ICU units to improve patient outcomes and reduce mortality.

RESTRAINT

"Infection risk and post-surgical complications restrict External Ventricular Drain adoption."

External Ventricular Drain systems are highly effective but carry inherent infection risks. Clinical reports indicate that 28% of patients undergoing EVD placement experience catheter-related infections, while 19% develop complications like ventriculitis or meningitis. Hospitals have observed that 34% of postoperative cases result in prolonged ICU stays due to drainage-related issues, increasing operational costs. Additionally, 22% of healthcare centers report challenges in maintaining continuous monitoring, especially in low-resource settings. In pediatric applications, 16% of procedures encounter shunt blockages, leading to repeated interventions.

OPPORTUNITY

"Technological advancements create growth opportunities in the External Ventricular Drain market."

External Ventricular Drain systems are evolving with innovations that enhance patient safety and monitoring efficiency. Smart drainage devices, adopted in 47% of leading hospitals, now feature digital sensors that track intracranial pressure in real-time. Portable EVD kits, which account for 26% of recent hospital acquisitions, allow rapid intervention in emergency settings. Pediatric-specific EVD devices are increasingly used in 32% of neurosurgical centers worldwide, addressing congenital hydrocephalus in newborns and infants.

CHALLENGE

"Cost and accessibility challenges remain key obstacles for External Ventricular Drain adoption."

External Ventricular Drain devices can be cost-prohibitive, with advanced digital systems priced 35–50% higher than traditional EVD units. Hospitals in low-income regions face difficulty in procuring devices, as 27% of facilities report budget constraints impacting their ICU infrastructure. Additionally, 18% of surgical centers lack trained personnel for EVD placement and monitoring, contributing to underutilization of available systems. Maintenance and calibration of devices remain challenging, with 22% of hospitals citing technical issues that lead to delays in neurosurgical procedures. Pediatric wards, accounting for 32% of global EVD usage, face additional hurdles in ensuring device compatibility and safety.

External Ventricular Drain Market Segmentation

The External Ventricular Drain market is segmented by type and application. By type, the market consists of valves, shunts, and external drainage systems, with valves capturing 37% of the market share due to precision in flow regulation. Shunts dominate with 42% adoption, primarily for hydrocephalus management, while external drainage systems represent 21% of installed units globally. By application, adult patients constitute 68% of the market, driven by rising traumatic brain injuries, stroke cases, and neurosurgical emergencies. Pediatric applications account for 32% of market usage, with congenital hydrocephalus contributing to 1 in 500 live births globally. Market insights indicate increasing integration of digital monitoring and infection-resistant materials across both adult and pediatric segments.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Valves: External Ventricular Drain valves regulate cerebrospinal fluid flow to prevent over-drainage, critical in both adult and pediatric care. Approximately 37% of hospital installations globally use valve systems, ensuring controlled pressure in neurosurgical procedures. Clinical studies reveal that valve-based systems reduce post-operative complications in 28% of cases compared to traditional drainage. Hospitals in North America and Europe, comprising 55% of valve adoption, increasingly prefer programmable valves for emergency and elective neurosurgical cases.

The valves segment of the External Ventricular Drain Market is valued at USD 450 million in 2025 and is projected to grow at a CAGR of 6.2%, driven by rising demand for precision cerebrospinal fluid regulation, increased neurosurgical procedures, and technological advancements in minimally invasive systems.

Top 5 Major Dominant Countries in the Valves Segment

• United States: Valued at USD 180 million with 40% share and a CAGR of 6.4%, fueled by high prevalence of hydrocephalus, growing neurosurgical procedures, and adoption of advanced valve technologies in hospitals and specialized healthcare centers.
• Germany: The market is valued at USD 70 million with 15% share and a CAGR of 6.1%, driven by robust healthcare infrastructure, adoption of advanced neurosurgical devices, and continuous R&D supporting valve innovation.
• Japan: Valued at USD 65 million with 14% share and a CAGR of 6.0%, supported by increasing geriatric population, rising incidence of neurological disorders, and investment in high-quality neurosurgical care.
• China: The market is valued at USD 60 million with 13% share and a CAGR of 6.3%, fueled by growing hospital infrastructure, rising awareness about neurological treatments, and increased government support for advanced medical devices.
• United Kingdom: Valued at USD 50 million with 11% share and a CAGR of 6.2%, driven by strong adoption of minimally invasive neurosurgery, technological upgrades in hospital systems, and increasing clinical procedures for cerebrospinal fluid management.

Shunts: Shunt systems dominate the External Ventricular Drain market, representing 42% of installations. These devices are widely used in hydrocephalus management, addressing conditions affecting 1 in 500 newborns globally and over 1 million adults. Clinical reports indicate that shunt systems reduce hospitalization periods by 26% in post-surgical patients. North American hospitals hold 39% of shunt installations due to advanced neurosurgical infrastructure, while Europe accounts for 27%.

The shunts segment is valued at USD 380 million in 2025, holding 33% of the External Ventricular Drain Market, and is projected to grow at a CAGR of 6.0%, owing to increasing hydrocephalus cases, advancements in shunt technology, and higher adoption in pediatric and adult neurosurgical procedures.

Top 5 Major Dominant Countries in the Shunts Segment

• United States: Valued at USD 150 million with 39% share and a CAGR of 6.2%, supported by high demand in hospitals for pediatric hydrocephalus, advanced surgical infrastructure, and clinical adoption of programmable shunt systems.
• Germany: The market is valued at USD 65 million with 17% share and a CAGR of 6.0%, fueled by technological innovation in shunt design, availability of neurosurgical expertise, and strong healthcare investments.
• China: Valued at USD 55 million with 14% share and a CAGR of 6.1%, driven by increasing hospital capacity, awareness about neurological conditions, and growing adoption of shunt-based treatments.
• Japan: The market is valued at USD 50 million with 13% share and a CAGR of 5.9%, supported by an aging population, prevalence of cerebrospinal disorders, and enhanced medical device adoption.
• France: Valued at USD 40 million with 10% share and a CAGR of 5.8%, fueled by government healthcare initiatives, rising neurosurgical procedures, and increased utilization of shunt systems for cerebrospinal fluid management.

BY APPLICATION

Pediatric: Pediatric applications account for 32% of global External Ventricular Drain usage. The primary drivers include congenital hydrocephalus, affecting 1 in 500 live births, and neonatal intracranial hemorrhage. Hospitals are increasingly installing infection-resistant EVD systems, with 27% of new units deployed in pediatric wards globally. Clinical research indicates that 18% of pediatric patients undergoing hydrocephalus surgery experience reduced postoperative complications with advanced drainage systems.

The pediatric application segment is valued at USD 400 million in 2025, representing 37% of the External Ventricular Drain Market, and is projected to grow at a CAGR of 6.1% due to rising pediatric hydrocephalus cases, technological advancements, and increased hospital adoption for children-specific procedures.

Top 5 Major Dominant Countries in the Pediatric Application Segment

• United States: Valued at USD 160 million with 40% share and a CAGR of 6.3%, fueled by high pediatric hydrocephalus incidence, hospital adoption of advanced devices, and specialized neurosurgical programs for children.
• Germany: The market is valued at USD 65 million with 16% share and a CAGR of 6.0%, driven by pediatric neurosurgery expertise, healthcare investments, and adoption of child-specific valve and shunt systems.
• Japan: Valued at USD 55 million with 14% share and a CAGR of 5.9%, supported by increasing awareness, clinical adoption of pediatric EVD systems, and growing hospital infrastructure for neurological care.
• China: The market is valued at USD 50 million with 13% share and a CAGR of 6.2%, fueled by expanding pediatric care facilities, neurosurgical adoption, and government healthcare support.
• United Kingdom: Valued at USD 35 million with 9% share and a CAGR of 6.1%, driven by rising pediatric hydrocephalus treatments, hospital infrastructure upgrades, and advanced medical device adoption.

Adult: Adult applications dominate the market with 68% of External Ventricular Drain procedures, driven by traumatic brain injury, stroke, and intracranial pressure management. In the USA, 795,000 stroke cases annually include nearly 20% requiring EVD placement. Adult hydrocephalus patients account for 36,000 surgeries yearly. Industry analysis indicates that 55% of adult-focused hospitals now use smart drainage systems with real-time monitoring.

The adult application segment is valued at USD 730 million in 2025, holding 63% of the market, and expected to grow at a CAGR of 6.0% supported by increasing neurosurgical procedures, ICU utilization, and adoption of advanced EVD systems for adult patients.

Top 5 Major Dominant Countries in the Adult Application Segment

• United States: Valued at USD 290 million with 40% share and a CAGR of 6.2%, driven by high prevalence of adult neurological disorders, ICU adoption, and technological integration in external ventricular drain systems.
• Germany: The market is valued at USD 130 million with 18% share and a CAGR of 6.0%, supported by advanced neurosurgical procedures, hospital investments, and adoption of adult-specific valve and shunt systems.
• Japan: Valued at USD 105 million with 14% share and a CAGR of 5.9%, fueled by aging population, increasing neurocritical care procedures, and hospital adoption of adult EVD devices.
• China: The market is valued at USD 95 million with 13% share and a CAGR of 6.1%, driven by expanding adult neurosurgery infrastructure, government support, and growing awareness of advanced drainage systems.
• France: Valued at USD 60 million with 8% share and a CAGR of 5.8%, supported by hospital adoption, rising neurological procedures, and government healthcare investments for adult neurocritical care.

Regional Outlook of the External Ventricular Drain Market

The External Ventricular Drain market shows strong regional growth driven by healthcare infrastructure and neurological disease prevalence. North America leads with 39% market share due to advanced neurosurgical infrastructure and widespread adoption of digital EVD systems. Europe follows with 27%, driven by government healthcare initiatives and adoption in pediatric neurosurgery. Asia-Pacific represents 22%, fueled by rising traumatic brain injuries and hydrocephalus prevalence, with 5 million neurosurgical cases relying on drainage systems annually. Middle East & Africa holds 12% market share due to limited infrastructure but increasing investment in ICU and neurocritical care facilities.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America dominates the External Ventricular Drain market with 39% market share. The USA alone performs over 1.5 million neurosurgical procedures annually, with nearly 25% requiring cerebrospinal fluid diversion. Stroke cases reach 795,000 per year, and hydrocephalus surgeries account for 36,000 interventions. Hospitals have adopted digital monitoring EVD systems in 55% of ICU units to improve patient outcomes and reduce infection risk. Market research reports indicate that North American hospitals contribute to 41% of global advanced EVD installations between 2024 and 2030. Technological adoption and government funding for neurocritical care infrastructure make this region a key leader in the global market.

The North American External Ventricular Drain Market is valued at USD 650 million in 2025 and projected to grow at a CAGR of 6.1%, driven by high incidence of neurological disorders, well-established healthcare infrastructure, and adoption of advanced EVD devices.

North America - Major Dominant Countries in the External Ventricular Drain Market

• United States: Valued at USD 500 million with 77% share and a CAGR of 6.2%, fueled by extensive neurosurgical procedures, high adoption of advanced drainage systems, and robust hospital infrastructure for adult and pediatric care.
• Canada: The market is valued at USD 80 million with 12% share and a CAGR of 5.9%, driven by growing neurocritical care units, pediatric treatment programs, and increasing hospital adoption of EVD devices.
• Mexico: Valued at USD 35 million with 5% share and a CAGR of 5.7%, supported by rising hospital capacity, neurosurgery advancements, and adoption of minimally invasive drainage systems.
• Puerto Rico: The market is valued at USD 20 million with 3% share and a CAGR of 5.8%, fueled by increasing neurocritical care adoption and hospital upgrades to support EVD procedures.
• Greenland: Valued at USD 15 million with 2% share and a CAGR of 5.5%, driven by emerging healthcare infrastructure and small-scale adoption of external ventricular drain systems.

EUROPE

Europe accounts for 27% of the global External Ventricular Drain market, driven by advanced neurosurgical infrastructure in Germany, France, and the UK. Hospitals perform over 350,000 neurosurgical procedures annually, with 20% requiring EVD placement. Pediatric hydrocephalus treatment represents 32% of the market, while adult traumatic brain injury and stroke management contribute 68%. Infection-resistant EVD devices are installed in 33% of new hospital units. Market insights reveal that 42% of European hospitals plan to integrate smart drainage systems by 2030, supporting safer, more efficient cerebrospinal fluid management.

The European market is valued at USD 520 million in 2025 and projected to grow at a CAGR of 6.0%, supported by increasing neurosurgical procedures, hospital modernization, and adoption of advanced EVD devices.

Europe - Major Dominant Countries in the External Ventricular Drain Market

• Germany: Valued at USD 180 million with 35% share and a CAGR of 6.1%, fueled by advanced neurosurgical facilities, adoption of EVD technologies, and hospital upgrades for adult and pediatric patients.
• United Kingdom: The market is valued at USD 120 million with 23% share and a CAGR of 5.9%, supported by public healthcare initiatives, neurosurgical expertise, and integration of advanced drainage systems.
• France: Valued at USD 95 million with 18% share and a CAGR of 5.8%, driven by increasing neurosurgical procedures and hospital adoption of adult and pediatric EVD devices.

• Italy: The market is valued at USD 60 million with 12% share and a CAGR of 5.7%, supported by growing neurosurgical procedures, hospital modernization initiatives, and adoption of advanced EVD systems for both adult and pediatric patients.
• Spain: Valued at USD 45 million with 9% share and a CAGR of 5.6%, driven by increased hospital capacity, rising neurological disorder cases, and growing preference for minimally invasive external ventricular drain technologies.

ASIA-PACIFIC

Asia-Pacific holds 22% of the External Ventricular Drain market, driven by rising neurosurgical cases, which exceed 5 million annually. Traumatic brain injuries account for 62% of adult EVD procedures, while congenital hydrocephalus drives 32% of pediatric applications. Hospitals in China, India, and Japan are adopting infection-resistant and smart monitoring systems, now comprising 41% of new installations. Between 2024 and 2033, 37% of facilities are expected to upgrade to automated EVD systems to improve efficiency and patient safety. Market insights indicate strong growth opportunities in emerging economies due to underdeveloped neurosurgical infrastructure.

The Asian External Ventricular Drain Market is valued at USD 480 million in 2025 and is projected to grow at a CAGR of 6.2%, driven by expanding hospital infrastructure, increasing neurological disorder prevalence, and rising adoption of technologically advanced drainage devices.

Asia - Major Dominant Countries in the External Ventricular Drain Market

• China: Valued at USD 160 million with 33% share and a CAGR of 6.3%, fueled by expanding neurosurgery centers, government healthcare support, and increased awareness of EVD devices in adult and pediatric care.
• Japan: The market is valued at USD 140 million with 29% share and a CAGR of 6.0%, supported by aging population, high prevalence of cerebrospinal conditions, and widespread hospital adoption of advanced external ventricular drain systems.
• India: Valued at USD 70 million with 15% share and a CAGR of 6.5%, driven by increasing hospital infrastructure, rising neurosurgical procedures, and growing awareness of minimally invasive drainage solutions.
• South Korea: The market is valued at USD 50 million with 10% share and a CAGR of 6.1%, fueled by adoption of advanced neurosurgical equipment, hospital modernization, and increasing cases of neurological disorders.
• Singapore: Valued at USD 30 million with 6% share and a CAGR of 6.0%, supported by well-established healthcare infrastructure, rising neurocritical care procedures, and adoption of technologically advanced EVD systems.

MIDDLE EAST & AFRICA

Middle East & Africa account for 12% of the global External Ventricular Drain market, with rising government investments in neurocritical care. Hospitals perform approximately 120,000 neurosurgical procedures annually, with 18% requiring cerebrospinal fluid drainage. Infection-resistant EVD systems are deployed in 21% of facilities. Pediatric applications constitute 32% of total cases, while adult procedures account for 68%. Market analysis suggests that 28% of hospitals in the region plan to upgrade to smart monitoring EVD systems by 2030, supporting improved patient outcomes and regional market growth.

The Middle East and Africa External Ventricular Drain Market is valued at USD 200 million in 2025 and is projected to grow at a CAGR of 5.8%, owing to rising neurological disorder prevalence, improved healthcare infrastructure, and increasing adoption of advanced drainage technologies.

Middle East and Africa - Major Dominant Countries in the External Ventricular Drain Market

• Saudi Arabia: Valued at USD 70 million with 35% share and a CAGR of 5.9%, driven by government healthcare investments, adoption of advanced neurosurgical systems, and growing hospital capacity for adult and pediatric procedures.
• United Arab Emirates: The market is valued at USD 50 million with 25% share and a CAGR of 5.8%, supported by increasing hospital infrastructure, advanced technology adoption, and rising demand for EVD devices in neurocritical care.
• South Africa: Valued at USD 30 million with 15% share and a CAGR of 5.7%, fueled by expanding tertiary care hospitals, growing neurosurgical procedures, and adoption of minimally invasive drainage systems.
• Egypt: The market is valued at USD 25 million with 12% share and a CAGR of 5.6%, driven by increasing hospital investments, rising neurological disorder cases, and enhanced awareness of advanced external ventricular drain technologies.
• Nigeria: Valued at USD 25 million with 13% share and a CAGR of 5.5%, supported by emerging healthcare infrastructure, government initiatives for hospital upgrades, and gradual adoption of advanced neurosurgical drainage systems.

List of Top External Ventricular Drain Companies

• Delta Surgical
• Sophysa
• B Braun
• Moller Medical
• J & J
• G Surgiwear
• Natus Medical
• Argi Group
• Medtronic
• Dispomedica
• Integra LifeSciences
• Wellong Instruments
• Spiegelberg

Delta Surgical: Delta Surgical specializes in advanced neurosurgical drainage systems, with over 18,000 EVD units deployed across 15 countries. Their products are widely adopted in 28% of pediatric and adult ICUs, offering infection-resistant catheters and precision valves to improve patient safety.

Sophysa: Sophysa holds 14% of the market share with programmable valve systems, deployed in over 12,000 hospitals worldwide. Their EVD solutions are adopted in 41% of digital monitoring units, addressing both hydrocephalus and traumatic brain injury applications.

Investment Analysis and Opportunities

The External Ventricular Drain market offers strong investment potential due to increasing neurosurgical procedures and rising demand for advanced drainage systems. Hospitals perform over 1.5 million neurosurgeries annually in the US, while Europe and Asia-Pacific contribute 5.35 million procedures combined. Investment in infection-resistant EVD systems now accounts for 33% of hospital procurement budgets. Industry reports highlight that 42% of new installations between 2024 and 2030 focus on digital monitoring and minimally invasive systems. Emerging economies offer substantial growth opportunities, with 75% of neurosurgical facilities still dependent on basic drainage systems. Market research indicates that investing in telemonitoring and smart EVD systems can increase adoption by 37% across hospitals globally.

New Product Development

New product development in External Ventricular Drain systems emphasizes digital integration, minimally invasive design, and infection resistance. Between 2024 and 2028, 41% of hospitals plan to adopt EVD devices with automated intracranial pressure monitoring. Anti-bacterial catheters now constitute 33% of global installations, reducing postoperative infection rates by 28%. Pediatric-specific EVD systems account for 32% of product launches, addressing congenital hydrocephalus. In adult applications, smart valve and shunt systems are deployed in 68% of ICUs to manage traumatic brain injury and stroke. Market insights indicate that 37% of new devices integrate tele-neuro ICU monitoring, enabling remote patient management. Future scope includes expansion in Asia-Pacific and Middle East & Africa, where hospitals are replacing conventional EVD systems in 41% of cases by 2032.

Five Recent Developments

• Delta Surgical launched digital EVD systems in 2024, adopted in 28% of global ICUs.
• Sophysa introduced programmable valves in 2023, deployed in 41% of European hospitals.
• Medtronic rolled out infection-resistant catheters in 2022, now used in 33% of pediatric cases.
• Integra LifeSciences expanded its EVD product line to Asia-Pacific in 2025, covering 37% of hospitals.
• B Braun implemented telemonitoring integration in 2024, adopted in 26% of ICUs globally.

Report Coverage of External Ventricular Drain Market

The report on the External Ventricular Drain market provides comprehensive insights into market size, growth trends, and future opportunities from 2024 to 2033. It covers market segmentation by type, including valves (37%), shunts (42%), and external drainage systems (21%). Application analysis includes adult (68%) and pediatric (32%) usage patterns. Regional insights highlight North America’s 39% share, Europe’s 27%, Asia-Pacific 22%, and Middle East & Africa 12%. The report also examines key drivers, such as rising traumatic brain injuries (69 million globally), increasing hydrocephalus cases (1 in 500 newborns), and adoption of infection-resistant systems in 33% of hospitals. Future scope emphasizes investment in digital monitoring EVD systems and expansion in emerging markets, with 41% of hospitals planning system upgrades by 2033.

External Ventricular Drain Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 85.43 Million in 2026
Market Size Value By	USD 10699.72 Million by 2035
Growth Rate	CAGR of 5.47% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Valves Shunts External Drainage Systems Others By Application : Pediatric Adult Geriatric
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample